Entera Bio Ltd. (ENTX) stock

ENTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 8/30

$3.11−0.11 (-3.42%)

Close on Nov 13, 2026Market cap $538.47MP/E –Yield –

Entera Bio total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Entera Bio's total debt was $3.89M at Dec 31, 2017. For fiscal 2017 it was $3.89M.

Period	Period end	Value	Change
FY2017	Dec 31, 2017	$3.89M	–

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q4 FY2017	Dec 31, 2017	$3.89M	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ENTX.

Advertisement
300 × 250

See a number that looks wrong?